Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Good
|
New words:
absorbed, aggressively, beneficial, Candida, carcinogenic, carcinogenicity, Colbex, deemed, depreciation, dermal, dismissal, dismissed, element, entirety, forfeiture, inadvertent, joined, leverage, mice, microbial, modestly, Motion, payer, Pharma, post, prejudice, prepaid, prolonged, promptly, qui, registered, resistance, semi, settlement, slightly, statute, talented, tam, timeframe, tinea, undesirable, versicolor, voluntarily
Removed:
actively, added, Alfred, allege, Altomari, attempt, Biogen, building, Cauwenbergh, commitment, complementary, consideration, delivered, divided, Dr, employment, equipment, establishing, fleet, furniture, Geert, hiring, Idec, interference, Kingdom, launching, man, merit, misappropriation, monitoring, mutual, operate, opposition, pharmacokinetic, preliminary, presently, priority, promissory, recruit, Sebazole, short, Spain, subsequently, terminable, Trademark, undelivered, vigorously
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 31.1 Certification of Principal Executive Officer Required by Rule 13A-14(A)
- 31.2 Certification of Principal Financial Officer Required by Rule 13A-14(A)
- 31.3 Certification of Principal Accounting Officer Required by Rule 13A-14(A)
- 32.1 Section 1350 Certification of Principal Executive Officer
- 32.2 Section 1350 Certification of Principal Financial Officer
- 32.3 Section 1350 Certification of Principal Accounting Officer
Related press release
Barrier Therapeutics similar filings
Filing view
External links